vs
STANDARD BIOTOOLS INC.（LAB）与Orange County Bancorp, Inc.（OBT）财务数据对比。点击上方公司名可切换其他公司
Orange County Bancorp, Inc.的季度营收约是STANDARD BIOTOOLS INC.的1.7倍（$33.0M vs $19.6M），Orange County Bancorp, Inc.净利率更高（37.6% vs -177.4%，领先215.0%），Orange County Bancorp, Inc.同比增速更快（20.6% vs -11.5%），Orange County Bancorp, Inc.自由现金流更多（$41.3M vs $-23.1M），过去两年Orange County Bancorp, Inc.的营收复合增速更高（14.3% vs -12.2%）
Standard BioTools（原Fluidigm公司）是一家美国生命科学工具企业，主营流式细胞术与组织成像分析用质谱流式系统，以及配套的检测试剂盒与试剂，同时供应自动化基因组分析仪器、各类微流控芯片（又称集成流体电路）及配套试剂耗材，全系列产品及应用场景均可提供定制检测方案与相关服务。
奥兰治县银行控股公司注册于美国特拉华州，主要在纽约州开展业务，为个人消费者、小微企业及中型企业客户提供全面的零售与商业银行服务，涵盖存款账户、各类贷款、财富管理解决方案等金融产品。
LAB vs OBT — 直观对比
损益表 — Q3 FY2025 vs Q4 FY2025
| 指标 | | |
|---|---|---|
| 营收 | $19.6M | $33.0M |
| 净利润 | $-34.7M | $12.4M |
| 毛利率 | 48.5% | — |
| 营业利润率 | -168.5% | 41.4% |
| 净利率 | -177.4% | 37.6% |
| 营收同比 | -11.5% | 20.6% |
| 净利润同比 | -28.8% | 73.5% |
| 每股收益（稀释后） | $-0.09 | $0.94 |
绿色 = 该指标领先。财年不对齐时期间可能不同
8季度营收与利润趋势
并排季度历史对比，按日历期对齐，财年错位的公司也能正确匹配
| Q4 25 | — | $33.0M | ||
| Q3 25 | $19.6M | $33.7M | ||
| Q2 25 | $21.8M | $32.5M | ||
| Q1 25 | $40.8M | $28.0M | ||
| Q4 24 | — | $27.4M | ||
| Q3 24 | $22.1M | $27.1M | ||
| Q2 24 | $22.5M | $27.9M | ||
| Q1 24 | $45.5M | $25.3M |
| Q4 25 | — | $12.4M | ||
| Q3 25 | $-34.7M | $10.0M | ||
| Q2 25 | $-33.5M | $10.5M | ||
| Q1 25 | $-26.0M | $8.7M | ||
| Q4 24 | — | $7.2M | ||
| Q3 24 | $-26.9M | $3.2M | ||
| Q2 24 | $-45.7M | $8.2M | ||
| Q1 24 | $-32.2M | $9.3M |
| Q4 25 | — | — | ||
| Q3 25 | 48.5% | — | ||
| Q2 25 | 48.8% | — | ||
| Q1 25 | 48.4% | — | ||
| Q4 24 | — | — | ||
| Q3 24 | 54.9% | — | ||
| Q2 24 | 46.1% | — | ||
| Q1 24 | 53.1% | — |
| Q4 25 | — | 41.4% | ||
| Q3 25 | -168.5% | 38.6% | ||
| Q2 25 | -118.1% | 41.9% | ||
| Q1 25 | -80.8% | 40.3% | ||
| Q4 24 | — | 32.8% | ||
| Q3 24 | -120.9% | 14.8% | ||
| Q2 24 | -134.5% | 36.6% | ||
| Q1 24 | -132.2% | 45.9% |
| Q4 25 | — | 37.6% | ||
| Q3 25 | -177.4% | 29.7% | ||
| Q2 25 | -153.7% | 32.2% | ||
| Q1 25 | -63.8% | 31.1% | ||
| Q4 24 | — | 26.2% | ||
| Q3 24 | -122.0% | 11.8% | ||
| Q2 24 | -203.3% | 29.4% | ||
| Q1 24 | -70.6% | 36.7% |
| Q4 25 | — | $0.94 | ||
| Q3 25 | $-0.09 | $0.75 | ||
| Q2 25 | $-0.09 | $0.87 | ||
| Q1 25 | $-0.07 | $0.77 | ||
| Q4 24 | — | $0.64 | ||
| Q3 24 | $-0.07 | $0.28 | ||
| Q2 24 | $-0.12 | $0.73 | ||
| Q1 24 | $-0.27 | $0.82 |
资产负债表与财务实力
最新季度各公司的流动性、杠杆与账面价值一览
| 指标 | | |
|---|---|---|
| 现金及短期投资手头流动性 | $129.4M | — |
| 总债务越低越好 | — | — |
| 股东权益账面价值 | $399.7M | $284.4M |
| 总资产 | $539.6M | $2.7B |
| 负债/权益比越低杠杆越低 | — | — |
8季度趋势，按日历期对齐
| Q4 25 | — | — | ||
| Q3 25 | $129.4M | — | ||
| Q2 25 | $158.6M | — | ||
| Q1 25 | $150.9M | — | ||
| Q4 24 | — | — | ||
| Q3 24 | $210.6M | — | ||
| Q2 24 | $269.8M | — | ||
| Q1 24 | $287.1M | — |
| Q4 25 | — | — | ||
| Q3 25 | — | — | ||
| Q2 25 | — | — | ||
| Q1 25 | — | — | ||
| Q4 24 | — | — | ||
| Q3 24 | $55.2M | — | ||
| Q2 24 | $55.1M | — | ||
| Q1 24 | $55.0M | — |
| Q4 25 | — | $284.4M | ||
| Q3 25 | $399.7M | $270.1M | ||
| Q2 25 | $424.5M | $252.6M | ||
| Q1 25 | $454.6M | $201.3M | ||
| Q4 24 | — | $185.5M | ||
| Q3 24 | $489.3M | $193.1M | ||
| Q2 24 | $510.3M | $177.5M | ||
| Q1 24 | $577.3M | $168.7M |
| Q4 25 | — | $2.7B | ||
| Q3 25 | $539.6M | $2.6B | ||
| Q2 25 | $557.0M | $2.6B | ||
| Q1 25 | $579.6M | $2.6B | ||
| Q4 24 | — | $2.5B | ||
| Q3 24 | $681.5M | $2.5B | ||
| Q2 24 | $708.7M | $2.5B | ||
| Q1 24 | $777.7M | $2.5B |
| Q4 25 | — | — | ||
| Q3 25 | — | — | ||
| Q2 25 | — | — | ||
| Q1 25 | — | — | ||
| Q4 24 | — | — | ||
| Q3 24 | 0.11× | — | ||
| Q2 24 | 0.11× | — | ||
| Q1 24 | 0.10× | — |
现金流与资本效率
扣除再投资后实际产生的现金。现金流比净利润更难造假
| 指标 | | |
|---|---|---|
| 经营现金流最新季度 | $-22.2M | $43.8M |
| 自由现金流经营现金流 - 资本支出 | $-23.1M | $41.3M |
| 自由现金流率自由现金流/营收 | -118.1% | 125.1% |
| 资本支出强度资本支出/营收 | 4.5% | 7.6% |
| 现金转化率经营现金流/净利润 | — | 3.53× |
| 过去12个月自由现金流最近4个季度 | $-111.1M | $69.6M |
8季度趋势，按日历期对齐
| Q4 25 | — | $43.8M | ||
| Q3 25 | $-22.2M | $30.2M | ||
| Q2 25 | $-20.7M | $-5.0M | ||
| Q1 25 | $-30.3M | $4.8M | ||
| Q4 24 | — | $34.6M | ||
| Q3 24 | $-27.9M | $10.2M | ||
| Q2 24 | $-39.0M | $9.3M | ||
| Q1 24 | $-62.5M | $2.3M |
| Q4 25 | — | $41.3M | ||
| Q3 25 | $-23.1M | $29.6M | ||
| Q2 25 | $-22.6M | $-5.7M | ||
| Q1 25 | $-35.3M | $4.3M | ||
| Q4 24 | — | $32.9M | ||
| Q3 24 | $-30.1M | $10.0M | ||
| Q2 24 | $-41.0M | $9.2M | ||
| Q1 24 | $-63.3M | $2.0M |
| Q4 25 | — | 125.1% | ||
| Q3 25 | -118.1% | 87.8% | ||
| Q2 25 | -103.6% | -17.5% | ||
| Q1 25 | -86.6% | 15.5% | ||
| Q4 24 | — | 120.0% | ||
| Q3 24 | -136.4% | 36.7% | ||
| Q2 24 | -182.2% | 32.8% | ||
| Q1 24 | -138.9% | 7.9% |
| Q4 25 | — | 7.6% | ||
| Q3 25 | 4.5% | 1.8% | ||
| Q2 25 | 8.7% | 2.3% | ||
| Q1 25 | 12.4% | 1.8% | ||
| Q4 24 | — | 6.3% | ||
| Q3 24 | 10.2% | 1.1% | ||
| Q2 24 | 8.6% | 0.4% | ||
| Q1 24 | 1.7% | 1.0% |
| Q4 25 | — | 3.53× | ||
| Q3 25 | — | 3.01× | ||
| Q2 25 | — | -0.47× | ||
| Q1 25 | — | 0.56× | ||
| Q4 24 | — | 4.83× | ||
| Q3 24 | — | 3.19× | ||
| Q2 24 | — | 1.13× | ||
| Q1 24 | — | 0.24× |
财务流量对比
营收 → 毛利润 → 营业利润 → 净利润流向图
业务分部营收拆解
LAB
| Consumables | $8.7M | 45% |
| Services And Other Revenue | $5.8M | 29% |
| Instruments | $5.1M | 26% |
OBT
暂无分部数据
